MedTrace Logo

Assessing the Effect of Sustainable Small-scale Egg Production on Maternal and Child Nutrition in Rural Zambia

NCT02516852 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3546

Last updated 2018-02-06

No results posted yet for this study

Summary

Animal source foods (ASF), such as meat and eggs, are rich in nutrients critical for growth and development. Yet, for poor children in developing countries, ASF consumption is limited by cost, inadequate caregiver knowledge, and lack of local production and physical availability. The impact of HH- and village-level livestock interventions on household dietary diversity and nutritional status in resource-poor communities is not well established. The objective of this study is to test the effectiveness of local egg production intervention on maternal and child diets and child nutrition status.

This project takes place in the Luangwa Valley, Zambia in partnership with a local non-governmental organization, COMACO. Twenty communities will be assigned to the intervention, and 20 matched communities will be selected as controls. In each intervention community, an egg production facility will be built, owned, and operated by trained COMACO farmers.

Households (HHs) in each community will be sampled twice annually for 1 year pre-intervention (baseline) and 1 year post-intervention to assess dietary diversity and nutritional status. Data analysis will test for a change in these outcomes from baseline in each intervention community compared to the matched control community.

Conditions

  • Malnutrition, Child
  • Malnutrition, Infant

Interventions

OTHER

Egg production

Establishment and support of a community-owned and -operated egg production facility located at a central location in the community

Sponsors & Collaborators

  • Community Markets for Conservation (COMACO)

    collaborator UNKNOWN

  • Cornell University

    lead OTHER

Principal Investigators

  • Alexander J Travis, VMD, PhD · Cornell University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
36 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2016-07-31
Completion
2017-05-31

Countries

  • Zambia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02516852 on ClinicalTrials.gov